Updated:
Beijing Hotgen Biotech
Beijing Hotgen Biotech was established in 2005 by Lin Changqing along with co-founders Jingjing Zhou, Hongshan Wei, and Xiaolan Yang. The firm conducts...
Overview
Beijing Hotgen Biotech was established in 2005 by Lin Changqing along with co-founders Jingjing Zhou, Hongshan Wei, and Xiaolan Yang. The firm conducts research, manufacturing, and sales of medical and public safety clinical products from its base in Beijing. The company holds a position on the Shanghai Stock Exchange. Its operations include a headquarters in the Daxing Biomedicine Industry Base and a production plant in the Langfang Economic and Technological Development Zone. No specific portfolio holdings or co-investors appear in public records. Lin Changqing continues to serve as the primary operating principal. The firm maintains two documented sites in China with no additional offices disclosed. No operational events from the last 24 months have been identified in available sources.
General information
Firm type
Corporate Investor
Year founded
2005
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Building 7, Floors 1-5, No. 55, Qingfeng West Road, Daxing Biomedicine Industry Base, Zhongguancun Science Park, Beijing, China
Additional offices
Langfang, China
Principals
Lin Changqing
Founder, Chairman, and General Manager
Jingjing Zhou
Co-founder
Hongshan Wei
Co-founder
Xiaolan Yang
Co-founder
Sector focus
Frequently asked questions
Who runs investment decisions at Beijing Hotgen Biotech?
Lin Changqing serves as Founder, Chairman, and General Manager. Co-founders Jingjing Zhou, Hongshan Wei, and Xiaolan Yang hold documented roles from the founding period.
Where does Beijing Hotgen Biotech maintain its operations?
Headquarters sit in the Daxing Biomedicine Industry Base in Beijing. A production plant operates in the Langfang Economic and Technological Development Zone in Hebei.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: